Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and Hypertriglyceridemia
- 1 August 1996
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 16 (8), 941-947
- https://doi.org/10.1161/01.atv.16.8.941
Abstract
Hypertriglyceridemia and hyperlipidemia are common disorders associated with coronary artery disease and premature death. The proteins encoded by the apolipoprotein (apo) A-I/C-III/A-IV gene cluster are involved in the metabolism of both triglycerides and cholesterol. In a large sample of individuals from the ARIC study, six polymorphic markers were typed and plasma lipid values were measured to determine whether the well-established association between the Sst I S2 allele in the 3′-untranslated region of the apo C-III gene and hypertriglyceridemia was due to disequilibrium with variation in the 5′ regulatory region of the apo C-III gene. The Sst I polymorphism was significantly associated with hypertriglyceridemia (P=.006) but not with carotid artery wall thickness, plasma apo C-III levels, or elevated cholesterol. The frequency of the S2 allele was 0.14 in those with high triglyceride levels and 0.05 in those with low triglyceride levels. None of the 5′ flanking polymorphisms were significantly associated with any of the plasma lipids studied. There was substantial linkage disequilibrium between the Sst I polymorphism and each of the 5′ apo C-III polymorphisms; however, the significant association between the apo C-III haplotypes and hypertriglyceridemia (odds ratio, 4.0; P<.0001) was solely attributable to the effects of the Sst I polymorphism (odds ratio, 3.96). As a part of these analyses, we also defined a unique haplotype that is inversely associated with the occurrence of hypertriglyceridemia, suggesting further molecular analyses of this important gene region.Keywords
This publication has 43 references indexed in Scilit:
- SstI APO AI-CIII DNA polymorphism associated with lower levels of HDL cholesterol in a young population from south of ItalyAustralian and New Zealand Journal of Medicine, 1993
- Polymorphism of the mouse TNF-i locus: sequence studies of the 3'-untranslated region and first intronGene, 1993
- Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosisAtherosclerosis, 1993
- Plasma Triglyceride Level and Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1993
- DNA Restriction Polymorphisms of the Apolipoprotein AI-CIII-AIV Gene Cluster: a Genetic Determinant of Atherosclerosis in Type 2 (Non-insulin-dependent) Diabetes MellitusDiabetic Medicine, 1991
- DNA Polymorphisms of the Apolipoprotein AI/CIII/ AIV Gene Cluster Influence Plasma Cholesterol and Triglyceride Levels in the Mayans of the Yucatán Peninsula, MexicoHuman Heredity, 1991
- Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administrationAtherosclerosis, 1989
- Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia.JCI Insight, 1985
- Human apolipoprotein A-I--C-III gene complex is located on chromosome 11.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIAThe Lancet, 1983